Coates, L., Rahman, P., Mease, P., Shawi, M., Rampakakis, E., Kollmeier, A., . . . Tam, L. (2024). Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: Post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study. BioMed Central.
Cytowanie według stylu Chicago (wyd. 17)Coates, LC, et al. Continuous Improvement Through Differential Trajectories of Individual Minimal Disease Activity Criteria with Guselkumab in Active Psoriatic Arthritis: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study. BioMed Central, 2024.
Cytowanie według stylu MLA (wyd. 9)Coates, LC, et al. Continuous Improvement Through Differential Trajectories of Individual Minimal Disease Activity Criteria with Guselkumab in Active Psoriatic Arthritis: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study. BioMed Central, 2024.